Polyethylene glycol-polylysine-curcumin polymicelle as well as preparation method and application thereof

Through the self-assembly technology of polyethylene glycol-polylysine-curcumin polymicroblasts, the problems of medium and high costs of periodontitis treatment and antibiotic abuse are solved, and the efficient load-load and controlled release of curcumin is achieved, which enhances the Treatment effects and reduce drug resistance and phototoxicity.

CN118994604AActive Publication Date: 2024-11-22TIANJIN UNIV OF SCI & TECH

Patent Information

Application Number
CN202411017459.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-22
Estimated Expiration
2044-07-29

AI Technical Summary

Technical Problem

The existing treatment methods for periodontitis have problems such as high cost, high invasiveness, the production of drug-resistant strains and low drug bioavailability, and the phototoxicity and tissue penetration of traditional acoustic dynamics therapy are insufficient.

Method used

Develop a polyethylene glycol-polylysine-curcumin polymicroblast that binds N-[4-(2,5-dihydrogenase) through the reaction of 3,3'-thiodipropionate acid and curcumin Oxo-4-oxazolinyl)butyl]-2,2,2-trifluoroacetamide-modified polylysine forms curcumin derivatives with monosulfide bond links, and self-assembles to form nano micelles , improve the water solubility and packing capacity of curcumin.

Benefits of technology

It realizes efficient packing and controlled release of curcumin, enhances the therapeutic effect on periodontitis, reduces premature release in the blood circulation of drugs, has excellent biocompatibility and deep tissue penetration, and avoids Drug resistance and phototoxicity issues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994604A_ABST
    Figure CN118994604A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of compounds, and discloses a polyethylene glycol-polylysine-curcumin polymer as well as a preparation method and application thereof, the structural formula of the polyethylene glycol-polylysine-curcumin polymer is as shown in formula (I): # imgabs0 #, m represents 114-227, x represents 5-10, and y represents 4-8. Curcumin is used as a hydrophobic group to be grafted to a polyethylene glycol-polylysine material to help formation of micelles, a new curcumin dosage form is formed, and the curcumin is used as other hydrophobic drugs for treating periodontitis. The polyethylene glycol-polylysine-curcumin micelle is a novel curcumin dosage form, can be used as other hydrophobic drugs for treating periodontitis, and realizes controlled slow release of the drugs. And moreover, the micelle has good biocompatibility.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of compounds and relates to a nano preparation, in particular to a polyethylene glycol-polylysine-curcumin polymicelle, a preparation method and application thereof. Background Art

[0002] Periodontitis is a chronic inflammatory disease that affects the supporting structure of teeth. The disease is a complex bacteria-induced immune response that usually leads to bacterial overgrowth, mainly Porphyromonas gingivalis among Gram-negative anaerobic bacteria, which causes progressive and irreversible destruction of tooth supporting tissues, ultimately leading to alveolar bone resorption and tooth loss. It not only affects the beauty and chewing function of teeth, but is also closely related to systemic diseases such as diabetes, cardiovascular and cerebrovascular diseases, lung function, and Alzheimer's disease. Therefore, effective prevention and treatment of periodontitis is essential for maintaining human health. In addition to basic treatments such as maintaining oral hygiene, removing tartar, and filling cavities, mechanical debridement combined with local antibiotic therapy is still the main strategy for clinical treatment of periodontitis at this stage. However, this treatment still has certain disadvantages. Not only is the treatment cost expensive, but it also causes panic and postoperative pain to the treatment. In addition, frequent use or abuse of supplementary antibiotic treatment can easily induce the production of drug-resistant strains, and long-term use of antibacterial drugs can easily cause dysbiosis. Therefore, the development of more effective and non-invasive methods is very important for the treatment of periodontitis (Xin Y, Guo Z, Ma A, et al. A robust ROS generation nanoplatform combating periodontitis via sonodynamic / chemodynamic combination therapy [J]. Chemical Engineering Journal, 2023, 451.). At present, photodynamic therapy (PDT) has been applied to bacterial infections. They can play a broad-spectrum antibacterial or selective anti-anaerobic role, but still have great defects, such as low tissue penetration depth and severe phototoxicity after systemic administration of photosensitizers. Therefore, to combat deep periodontitis bacteria, ultrasound (US) and sonosensitizer-induced sonodynamic therapy (SDT) is considered, which is a treatment method that uses ultrasound to stimulate sonosensitizers to produce active substances to damage cells (Mchale AP, Callan JF, Nomikou N, et al. Sonodynamic therapy: concept, mechanism and application to cancer treatment [J]. Adv Exp Med Biol, 2016, 880: 429-450).The mechanism is mainly due to the fact that sonosensitizers produce reactive oxygen species (ROS) or reactive nitrogen species (RNS) under low-intensity periodic mechanical vibrations. In addition, the energy of ultrasound causes temperature rise and other non-thermal effects, which together lead to irreversible damage and apoptosis of bacteria (Qian XQ, Zheng YY, Chen Y, et al. Micro / nanoparticle augmented sonodynamic therapy (SDT): breaking the depth of shallow photoactivation [J]. Adv Mater, 2016, 28 (37): 8097-8129). SDT not only has deeper tissue penetration (> 10 cm), but also has no bacterial resistance, which makes it show great advantages compared with traditional photodynamic therapy (Rosenthal I, Sostaric JZ, Riesz P, et al. Sonodynamic therapy: a review of the synergistic effects of drugs and ultrasound [J]. Ultrason Sonochem, 2004, 11 (6): 349-363). SDT is composed of three main parts: sonosensitizer, ultrasound and oxygen. Sonosensitizer can be organic or inorganic, but traditional sonosensitizers are limited by phototoxicity and skin sensitivity. Therefore, the development of effective sonosensitizers is very important for sonodynamics.

[0003] Curcumin (Cur) is a symmetrical natural polyphenolic substance, which is mostly found in plants such as Curcuma, Acorus, Turmeric and Curcuma. It has been reported that Cur has multiple pharmacological activities such as antioxidant, anti-inflammatory and anti-tumor. In addition, it has the effects of protecting liver and kidney, inhibiting thrombosis, preventing myocardial infarction, lowering blood sugar and anti-rheumatic. However, Cur is an acidic polyphenolic substance, insoluble in ether and water, and cannot effectively penetrate the cell membrane. After oral administration, it cannot reach an effective therapeutic concentration and has low bioavailability. Therefore, improving the apparent solubility and dissolution of Cur in water is the primary measure to improve its oral absorption. In order to improve the efficacy of drug delivery systems and reduce side effects, the construction of nano controlled release carriers has become the focus of attention. Conjugated micelles are an excellent nanoscale self-immolating intracellular drug delivery carrier. As a nanomaterial, it has the advantages of higher skin permeability, high drug loading, controlled release of the load, and the ability to encapsulate different types of drugs. Chinese and foreign scholars have tried many composite modification methods, such as cyclodextrin-curcumin, liposome-curcumin, phospholipid-curcumin, etc. (Wu Lisha, Yu Hongying, Zeng Qingbing. Preparation and in vitro drug release of curcumin mPEG_(114)-PCL_(36) nanomicelles [J]. Chinese Journal of Experimental Traditional Chinese Medicine, 2013, 19(12): 53-58.). Although novel, the effective load content of traditional physical encapsulation nanocarriers is low, and the actual mass of nanocarriers reaching the entity is extremely limited, only 1% of the dosage. Therefore, high drug loading is of great significance for improving the drug delivery efficiency of drug carriers, facilitating drug delivery, and preventing toxicity caused by carrier materials. Summary of the invention

[0004] The purpose of the present invention is to overcome the deficiencies in the prior art and provide a polyethylene glycol-polylysine-curcumin polymer, a preparation method and an application thereof.

[0005] The technical solution adopted by the present invention to solve its technical problem is:

[0006] A polyethylene glycol-polylysine-curcumin polymicelle, the structural formula of which is shown in formula (I):

[0007]

[0008] Here, m represents 114 to 227, x represents 5 to 10, and y represents 4 to 8.

[0009] Furthermore, the average particle size of the polyethylene glycol-polylysine-curcumin polymicelles is 147.6 nm, and the average Zeta potential is 20.5 mV.

[0010] The method for preparing the polyethylene glycol-polylysine-curcumin polymicelles as described above comprises the following steps:

[0011] Acylation of 3,3'-thiodipropionic acid with oxalyl chloride to generate 3,3'-thiodipropionic acid chloride;

[0012] Mixing the curcumin solution with pyridine used as an acid binding agent to obtain a curcumin mixed solution;

[0013] The chlorinated 3,3'-thiodipropionic acid and curcumin mixed solution are stirred and mixed at a temperature below 0°C, reacted at room temperature for 3 to 5 hours, and purified to obtain a curcumin derivative containing a single sulfur bond;

[0014] Deprotecting polylysine modified by N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide to obtain deprotected modified polylysine;

[0015] The modified polylysine is subjected to a condensation reaction with N, N-diisopropylethylamine, and then mixed with a curcumin derivative containing a single sulfide bond activated by 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole carboxyl group, and stirred in the dark for 24 to 48 hours for an amidation reaction; the mixture is precipitated with ice ether, dialyzed and freeze-dried to obtain a polyethylene glycol-polylysine-curcumin polymer.

[0016] Furthermore, the step of acylation reaction of 3,3'-thiodipropionic acid with oxalyl chloride to generate chlorinated 3,3'-thiodipropionic acid is specifically as follows:

[0017] Dissolve 3,3'-thiodipropionic acid in anhydrous tetrahydrofuran, add co-solvent N,N-dimethylformamide, slowly add oxalyl chloride under stirring below 0°C, and then stir at room temperature for 2-3h to obtain chlorinated 3,3'-thiodipropionic acid;

[0018] Alternatively, the step of mixing the curcumin solution with pyridine used as an acid binding agent is specifically:

[0019] Dissolve curcumin in anhydrous tetrahydrofuran, add pyridine and stir to obtain a curcumin mixed solution;

[0020] Alternatively, the preparation steps of the curcumin derivative containing a single sulfide bond are specifically as follows:

[0021] Under the condition of below 0°C, slowly drop 3,3'-thiodipropionic acid chloride into the curcumin mixed solution and stir, while protecting from light, transfer to room temperature and stir for 3-5 hours. After the reaction is completed, remove anhydrous tetrahydrofuran by rotary evaporation, dissolve with dichloromethane, extract and wash with hydrochloric acid, collect the organic phase and spin dry to obtain a curcumin derivative containing a single sulfur bond;

[0022] The obtained curcumin derivative containing a single sulfide bond is dissolved in dichloromethane, and a mixed solution of dichloromethane and methanol is used as an eluent and a developing agent. The target product is confirmed by continuously spotting the plate until it is completely out of the column. The product is collected, spin-dried, and dried to obtain a purified curcumin derivative containing a single sulfide bond.

[0023] Alternatively, the specific preparation steps of the N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide modified polylysine are:

[0024] Methoxypolyethylene glycol amine and N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide are placed in a round-bottom flask, and N,N-dimethylformamide DMF is added to dissolve, and chloroform is used as a co-solvent to dissolve, and the mixture is vacuumed, protected by inert gas, and stirred at 40-50° C. to react; after 3 days, the reaction solution is treated by rotary evaporation under reduced pressure, and then dripped into ice ether drop by drop to precipitate a white flocculent precipitate, and the precipitate is filtered out with a Buchner funnel, and vacuum dried to obtain modified polylysine;

[0025] The modified polylysine was dissolved in 0.5N sodium hydroxide aqueous solution and stirred at room temperature for 2 to 5 hours. After the reaction, the reaction solution was placed in a dialysis bag with a molecular weight cutoff (MWCO) of 1000Da for water dialysis. The ultrapure water was replaced every 2 hours. After 24 hours, the sample in the dialysis bag was taken out and placed in a freeze dryer for freeze drying to obtain the modified polylysine with deprotected groups.

[0026] Further, the molar ratio of the 3,3'-thiodipropionic acid to oxalyl chloride is 1:1.2;

[0027] Alternatively, the molar ratio of curcumin to pyridine is 1:10;

[0028] Alternatively, the molar ratio of the chlorinated 3,3'-thiodipropionic acid to curcumin is 1:1;

[0029] Alternatively, when the dichloromethane and methanol mixture is used as the eluent, the volume ratio of dichloromethane:methanol is 400:3, and when the dichloromethane and methanol mixture is used as the developing solvent, the volume ratio of dichloromethane:methanol is 100:3;

[0030] Alternatively, the molar ratio of the methoxypolyethylene glycol amine to N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide is 1:15;

[0031] Alternatively, the methoxypolyethylene glycol amine is mPEG4000-mPEG12000.

[0032] Furthermore, the method further comprises the step of preparing polyethylene glycol-polylysine-curcumin nano-micelles from polyethylene glycol-polylysine-curcumin polymers, specifically:

[0033] The polyethylene glycol-polylysine-curcumin polymer is dissolved in N,N-dimethylformamide, and added into a dialysis bag with a molecular weight cutoff (MWCO) of 2000Da. Ultrapure water is selected as the medium, and the dialysis is performed in the dark for 24 hours. The ultrapure water is replaced every 2 hours for the first 12 hours, and every 6 hours for the next 12 hours. After 24 hours, the dialysis is stopped, the solution is centrifuged, the supernatant is filtered with a 0.45μm microporous water filter membrane, and the filtrate is placed in a freeze dryer for freeze drying, and the freeze-dried product is the polyethylene glycol-polylysine-curcumin nano-micelles.

[0034] Furthermore, the specific steps of the polyethylene glycol-polylysine-curcumin polymer are:

[0035] The purified curcumin derivative containing a single sulfide bond is dissolved in dichloromethane, and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole are added for activation, and the mixture is kept at room temperature in the dark for 3 to 4 hours to obtain the activated curcumin derivative containing a single sulfide bond;

[0036] N, N-diisopropylethylamine was dropped into the modified polylysine with deprotected groups, and then dichloromethane was added to completely dissolve it for condensation reaction;

[0037] The modified polylysine with the deprotected group after the condensation reaction is added to the activated curcumin derivative containing a single sulfide bond, and the reaction is carried out at 20-30°C in the dark for 24-48 hours. After the reaction is completed, the reaction solution is concentrated by vacuum rotary evaporation and dropped into ice ether to produce a yellow precipitate; the precipitate is filtered out by Buchner funnel, collected, dissolved in ethanol, and then placed in a dialysis bag with a molecular weight cutoff (MWCO) of 2000Da for dialysis, and ethanol is selected as the dialysis medium; the dialysis solution is replaced every 2 hours, and after dialysis in the dark for 24 hours, the substance in the dialysis bag is taken out for vacuum rotary evaporation to remove the solvent, and vacuum drying is performed to obtain a polyethylene glycol-polylysine-curcumin polymer.

[0038] Further, the molar ratio of the purified curcumin derivative containing a monosulfide bond, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and 1-hydroxybenzotriazole is 1.5:1:1;

[0039] Alternatively, the molar ratio of the deprotected modified polylysine and N,N-diisopropylethylamine is 1:5;

[0040] Alternatively, the molar ratio of the purified curcumin derivative containing a monosulfide bond to the deprotected modified polylysine is 1:2.5.

[0041] Use of the polyethylene glycol-polylysine-curcumin polymer as described above in drug delivery.

[0042] Use of the polyethylene glycol-polylysine-curcumin polymer as described above in the preparation of drugs for treating periodontitis.

[0043] The advantages and positive effects achieved by the present invention are:

[0044] 1. The polyethylene glycol-polylysine-curcumin polymicelle of the present invention is a chemical encapsulation method, which can encapsulate more curcumin, and its encapsulation amount can reach 16-20%, which can trigger on-demand payload delivery. This method can not only reduce the premature release of drugs in the blood circulation, but also achieve stimulus-responsive drug release after triggering.

[0045] 2. The polyethylene glycol-polylysine-curcumin polymicelle of the present invention has curcumin as a hydrophobic group and polyethylene glycol-polylysine as a hydrophilic shell, which can self-assemble to form micelles. The formation of micelles increases the water solubility of curcumin.

[0046] 3. The polyethylene glycol-polylysine-curcumin polymicelles of the present invention are linked by a single sulfur bond and will only break under specific conditions, such as ultrasound and places with high active oxygen content. The active oxygen content in the periodontitis microenvironment is several times that under normal conditions. The single sulfur bond is broken and curcumin can be released smoothly. The polyethylene glycol poly-lysine also has good biocompatibility.

[0047] 4. The polyethylene glycol-polylysine-curcumin polymicelle of the present invention connects curcumin as a hydrophobic group to the framework material of the nanoparticles to help form the nanoparticles, forming a new dosage form of curcumin, and serves as a carrier for other hydrophobic periodontitis treatment to achieve the purpose of combined medication.

[0048] 5. There are tiny nano ions in the polyethylene glycol-polylysine-curcumin polymicelles of the present invention, which are separated to prepare polyethylene glycol-polylysine-curcumin, and a new curcumin preparation is constructed. At the same time, the preparation can also be used as a carrier of other hydrophobic drugs for controlled release of periodontal diseases. The polyethylene glycol-polylysine-curcumin composite nanomicelles have the effects of long circulation, escape from endothelial cell phagocytosis, etc., and have excellent biocompatibility.

[0049] 6. Redox-responsive polymer-drug conjugate micelles are excellent nanoscale carriers for self-destructive intracellular drug delivery. In order to covalently link the polymer and the drug, a linker with a single sulfide bond, such as 3,3'-thiodipropionic acid, was used. Curcumin was selected as a model drug and conjugated with a multivalent methoxypolyethylene glycol-polylysine copolymer with 3,3'-thiodipropionic acid as a linker. The resulting polymer-curcumin conjugate is amphiphilic and can self-assemble into hydrodynamic micelles. Regardless of the type of linker, micelle disassembly was observed due to the collapse of the single sulfide bond in an ultrasound or ROS aggregation environment.

[0050] 7. The present invention uses curcumin as a hydrophobic group to graft onto a polyethylene glycol-polylysine material to help form micelles, thereby forming a new dosage form of curcumin, and as other hydrophobic drugs for treating periodontitis. The polyethylene glycol-polylysine-curcumin micelle is a new dosage form of curcumin, which can be used as other hydrophobic drugs for treating periodontitis to achieve controlled release of the drug. The micelle has good biocompatibility. BRIEF DESCRIPTION OF THE DRAWINGS

[0051] Figure 1 The infrared spectra of curcumin (a), polyethylene glycol-polylysine polymer (b) and polyethylene glycol-polylysine-curcumin polymicelle (c) in the present invention are shown;

[0052] Figure 2 is a hydrogen nuclear magnetic resonance spectrum of the polyethylene glycol-polylysine-curcumin polymicelles of the present invention;

[0053] Figure 3 is a size distribution diagram of polyethylene glycol-polylysine-curcumin polymicelles in the present invention;

[0054] Figure 4 is the Zeta potential distribution diagram of the polyethylene glycol-polylysine-curcumin polymicelles in the present invention;

[0055] Figure 5 is a critical micelle concentration diagram of polyethylene glycol-polylysine-curcumin polymicelles in the present invention;

[0056] Figure 6 is a ROS diagram of polyethylene glycol-polylysine-curcumin polymicelles in the present invention;

[0057] Figure 7 It is a particle size stability analysis diagram of the polyethylene glycol-polylysine-curcumin polymicelles in the present invention;

[0058] Figure 8 This is a pathological section diagram of the in vivo periodontitis treatment ability of the polyethylene glycol-polylysine-curcumin polymicelles of the present invention. DETAILED DESCRIPTION

[0059] The present invention will be further described below in conjunction with the embodiments. The following embodiments are descriptive rather than restrictive, and the protection scope of the present invention cannot be limited by the following embodiments.

[0060] The various experimental operations involved in the specific embodiments are all routine techniques in the art. For parts not specially annotated in this document, ordinary technicians in the art can implement them by referring to various commonly used reference books, scientific and technological literature or related instructions, manuals, etc. before the filing date of this invention.

[0061] A polyethylene glycol-polylysine-curcumin polymer, the structural formula of which is shown in formula (I):

[0062]

[0063] Here, m represents 114 to 227, x represents 5 to 10, and y represents 4 to 8.

[0064] In the polyethylene glycol-polylysine-curcumin polymicelle, curcumin is grafted onto the polymer as a hydrophobic group. It is part of the polymer structure, rather than simply encapsulated in the polymer. Therefore, its structure is stable and not easily decomposed due to partial release in the blood, so the curcumin's own efficacy can be better exerted. And curcumin as a hydrophobic group helps the polymer form nanoparticles.

[0065] The above-mentioned polyethylene glycol-polylysine-curcumin polymicelles graft curcumin as a hydrophobic group onto the skeleton material of the nanoparticles to help form nanoparticles, form a new dosage form of curcumin, and serve as a carrier for other hydrophobic treatments for periodontitis to achieve the purpose of combined medication.

[0066] There are tiny nano-ions in the polyethylene glycol-polylysine-curcumin polymer, which can be separated into polyethylene glycol-polylysine-curcumin, thus forming a new dosage form of curcumin, and it can be used as a carrier for other hydrophobic periodontitis treatments to achieve controlled release of drugs. Polyethylene glycol-polylysine-curcumin nano-micelles have good biocompatibility, as well as long circulation and the ability to escape phagocytosis of the reticuloendothelial system.

[0067] A method for preparing polyethylene glycol-polylysine-curcumin polymicelles comprises the following steps:

[0068] Acylation of 3,3'-thiodipropionic acid with oxalyl chloride to generate 3,3'-thiodipropionic acid chloride;

[0069] The curcumin solution is mixed with pyridine which is used as an acid-binding agent;

[0070] The chlorinated 3,3'-thiodipropionic acid and the curcumin mixed solution are stirred and mixed at sub-zero temperature, reacted at room temperature for 3 to 5 hours, and purified to obtain a curcumin derivative containing a single sulfur bond;

[0071] The polylysine modified by N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide was subjected to a deprotection group treatment;

[0072] The modified polylysine is subjected to a condensation reaction with N, N-diisopropylethylamine, and then mixed with a curcumin derivative containing a single sulfide bond activated by 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole carboxyl group, and stirred in the dark for 24 to 48 hours for an amidation reaction; the mixture is precipitated with ice ether, dialyzed and freeze-dried to obtain a polyethylene glycol-polylysine-curcumin polymer.

[0073] The above-mentioned polyethylene glycol-polylysine-curcumin nano-micelles are made of polyethylene glycol, polylysine, curcumin, and 3,3'-thiodipropionic acid as raw materials. Curcumin and 3,3'-thiodipropionic acid at a molar ratio of 1:1 react to generate curcumin containing a single sulfide bond. Polyethylene glycol reacts with N,N-dimethylformamide to generate carboxylated polyethylene glycol (mPEGS). In the presence of a catalyst, the carboxylated polyethylene glycol reacts with polylysine to generate a polyethylene glycol-polylysine polymer. In the presence of a catalyst, curcumin containing a single sulfide bond reacts with the polyethylene glycol-polylysine polymer to generate a polyethylene glycol-polylysine-curcumin polymer mPEG-Plys (Cur). PCC is an amphiphilic polymer that can form polymer micelle nanoparticles by self-assembly in water.

[0074] (1) Synthesis of carboxylated curcumin (Cur-S-COOH): 3,3'-thiodipropionic acid was dissolved in anhydrous tetrahydrofuran (THF), N,N-dimethylformamide (DMF) was added dropwise to the solution, the solution was placed in cold hydrazine, stirred at below 0°C, and oxalyl chloride was slowly added dropwise thereto, and stirred at room temperature for 2 to 3 hours. This reaction solution is referred to as solution 1.

[0075] Curcumin was dissolved in anhydrous tetrahydrofuran, and pyridine was added dropwise to the solution for stirring. This solution was called solution 2. Solution 2 was placed in cold hydrazine, stirred below 0°C, and solution 1 was slowly added thereto, protected from light, and stirred at room temperature for 3 to 5 hours. After the reaction was completed, tetrahydrofuran was removed by rotary evaporation, and then dichloromethane was added to dissolve. After complete dissolution, the solution was transferred to a separatory funnel, and hydrochloric acid solution was added thereto for washing. After washing was repeated three times, the organic phase was collected and dried by rotary evaporation.

[0076] Separate by column chromatography, using dichloromethane:methanol=400:3 (V / V, volume ratio) as eluent. Dissolve the sample obtained by spin drying with dichloromethane, slowly add the sample to the chromatography column with a rubber dropper, add the eluent for elution, and use dichloromethane:methanol=100:1 (V / V, volume ratio) as a developing agent to continuously apply the plate until the target product exits the column, collect the target product, spin dry the solvent, and then vacuum dry it for 24 hours to obtain Cur-S-COOH.

[0077] (2) Synthesis of mPEG-PLys(TFA): Methoxypolyethylene glycol amine and Lys(TFA)-NCA were placed in a round-bottom flask and N,N-dimethylformamide (DMF) was added to dissolve. The mixture was vacuumed and protected by argon. The reaction was stirred at 40-50°C. The reaction solution was concentrated by rotary evaporation under reduced pressure and then added dropwise to icy ether. A white flocculent precipitate was immediately formed. The precipitate was filtered out with a Buchner funnel and dried under vacuum to obtain the target product mPEG-PLys(TFA).

[0078] (3) Synthesis of mPEG-PLys: mPEG-PLys (TFA) was placed in a glass bottle, and sodium hydroxide aqueous solution was added and stirred for 2 to 5 hours. After the reaction, the reaction solution was placed in a dialysis bag with a molecular weight cutoff (MWCO) of 1000 Da for water dialysis, and ultrapure water was replaced every two hours. After 24 hours, the sample in the dialysis bag was taken and placed in a freeze dryer for freeze drying, which was the target product of this step.

[0079] (4) Synthesis of mPEG-PLys(Cur): Place Cur-S-COOH in a round-bottom flask, add dichloromethane and stir to dissolve, then add EDCI and HoBt to activate at room temperature in the dark for 2 hours. This reaction yields solution 3.

[0080] mPEG-Plys was placed in a 25 mL round-bottom flask, DIPEA was added, and then dichloromethane was added to completely dissolve it. This solution was called Solution 4.

[0081] Solution 4 was slowly added dropwise to solution 3, and the rubber stopper was plugged. The reaction was carried out at 20-30°C in the dark for 24-48 hours. During this process, the solution gradually changed from orange-red to red. The reaction was stopped after 24 hours, and the reaction solution was concentrated by vacuum rotary evaporation. When the liquid volume was concentrated to 5 mL, it was dropped into ice ether to produce a large amount of yellow precipitate. The precipitate was filtered by Buchner funnel and collected in a small beaker. After adding alcohol to dissolve, it was loaded into a dialysis bag with a molecular weight cutoff (MWCO) of 2000Da. Ethanol was selected as the dialysis medium for dialysis. The dialysis solution was replaced every 2 hours. After 24 hours of dialysis, the substance in the dialysis bag was taken for vacuum rotary evaporation to remove the solvent, and vacuum drying was performed to obtain the final product mPEG-PLys (Cur).

[0082] Preferably, the molar ratio of 3,3'-thiodipropionic acid to oxalyl chloride is 1:1.2;

[0083] Alternatively, the molar ratio of curcumin to pyridine is 1:10;

[0084] Alternatively, the molar ratio of the chlorinated 3,3'-thiodipropionic acid to curcumin is 1:1;

[0085] Alternatively, when the dichloromethane and methanol mixture is used as the eluent, the volume ratio of dichloromethane:methanol is 400:3, and when the dichloromethane and methanol mixture is used as the developing solvent, the volume ratio of dichloromethane:methanol is 100:3;

[0086] Alternatively, the molar ratio of the methoxypolyethylene glycol amine to N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide is 1:15;

[0087] Alternatively, the methoxypolyethylene glycol amine is mPEG4000-mPEG12000.

[0088] Preferably, the molar ratio of the purified curcumin derivative containing a monosulfide bond, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and 1-hydroxybenzotriazole is 1.5:1:1;

[0089] Alternatively, the molar ratio of the deprotected modified polylysine and N,N-diisopropylethylamine is 1:5;

[0090] Alternatively, the molar ratio of the purified curcumin derivative containing a monosulfide bond to the deprotected modified polylysine is 1:2.5.

[0091] A method for preparing drug-loaded polyethylene glycol-polylysine-curcumin nanoparticles comprises the following steps:

[0092] The drug for treating periodontitis is dissolved in N,N-dimethylformamide, added to a dialysis bag with a molecular weight cutoff (MWCO) of 2000Da, and dialyzed for 24 hours in the dark. The solution is centrifuged, the supernatant is filtered with a 0.45μm microporous water filter membrane, the filtrate is placed in a freeze dryer and freeze-dried, and the freeze-dried product is polyethylene glycol-polylysine-curcumin nano micelles. Preferably, the dialysis process is: ultrapure water is changed every 2 hours for the first 12 hours, and ultrapure water is changed every 6 hours for the last 12 hours.

[0093] Specifically, the relevant preparation and detection are as follows:

[0094] Example 1: Chemical Synthesis of Polyethylene Glycol-Polylysine-Curcumin Polymer (PCC)

[0095] (1) Synthesis of carboxylated curcumin (Cur-S-COOH): Accurately weigh 0.36 g of 3,3'-thiodipropionic acid and place it in a 100 mL round-bottom flask. Add 20 mL of anhydrous tetrahydrofuran (THF) to dissolve it. Add 100 μL of N,N-dimethylformamide (DMF) to the solution. Place it in cold hydrazine, stir it below 0°C, and slowly add 210 μL of oxalyl chloride. Stir it at room temperature for 2 to 3 h. This reaction solution is called Solution 1.

[0096] Accurately weigh 0.74g of curcumin and place it in a 100mL round-bottom flask, add 20mL of anhydrous tetrahydrofuran to dissolve it, and then add 1.6mL of pyridine dropwise to the solution and stir it. This solution is called solution 2. Place solution 2 in cold hydrazine, stir below 0°C and slowly add solution 1 to it, avoid light, and stir at room temperature for 3 to 5 hours. After the reaction is completed, remove tetrahydrofuran by rotary evaporation, then add dichloromethane to dissolve it. After complete dissolution, transfer the solution to a separatory funnel, add 0.1N hydrochloric acid solution to it for washing, repeat the washing three times, and collect the organic phase and spin dry it.

[0097] Separate by column chromatography, using dichloromethane:methanol=400:3 (V / V, volume ratio) as eluent. Dissolve the sample obtained by spin drying with dichloromethane, slowly add the sample to the chromatography column with a rubber dropper, add the eluent for elution, and use dichloromethane:methanol=100:1 (V / V, volume ratio) as a developing agent to continuously apply the plate until the target product exits the column, collect the target product, spin dry the solvent, and then vacuum dry it for 24 hours to obtain Cur-S-COOH.

[0098] (2) Synthesis of mPEG-PLys(TFA): Accurately weigh 0.5 g of methoxypolyethylene glycol amine and 0.4 g of Lys(TFA)-NCA (i.e., N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide) into a 25 mL round-bottom flask, and add 8 mL of N,N-dimethylformamide (DMF) to dissolve. Vacuum, protect with argon, stir and react at 40-50°C. After the reaction solution is concentrated by rotary evaporation under reduced pressure, it is added dropwise to 100 mL of icy ether. A white flocculent precipitate is immediately formed. The precipitate is filtered off with a Buchner funnel and dried under vacuum to obtain the target product mPEG-PLys(TFA).

[0099] (3) Synthesis of polyethylene glycol-polylysine polymer (mPEG-PLys): Accurately weigh 0.8 g of mPEG-PLys (TFA) into a 20 mL glass bottle, add 10 mL of 0.5 N sodium hydroxide aqueous solution and stir to dissolve, cover the bottle cap, and stir to react at room temperature for 5 hours. After the reaction, the reaction solution was placed in a dialysis bag with a molecular weight cutoff (MWCO) of 1000 Da and dialyzed with water. Ultrapure water was replaced every two hours. After 24 hours, the sample in the dialysis bag was taken and placed in a freeze dryer for freeze drying to obtain polyethylene glycol-polylysine polymer.

[0100] (4) Synthesis of polyethylene glycol-polylysine-curcumin polymer: Accurately weigh 0.5 g of Cur-S-COOH and place it in a 25 mL round-bottom flask. Add 10 mL of dichloromethane and stir to dissolve. Continue to add 1.0 g of EDCI and 0.09 g of HoBt. Activate at room temperature in the dark for 2 hours. This reaction yields solution 3.

[0101] Accurately weigh 0.2 g of mPEG-PLys in step (3) into a 25 mL round-bottom flask, add 0.2 mL of DIPEA and then add 10 mL of dichloromethane to completely dissolve it. This solution is called solution 4.

[0102] Solution 4 was slowly added dropwise to solution 3, and the rubber stopper was plugged. The reaction was carried out at 30°C in the dark for 36 hours. During this process, the solution gradually changed from orange-red to red. The reaction was stopped after 24 hours, and the reaction solution was concentrated by vacuum rotary evaporation. When the liquid volume was concentrated to 5 mL, it was dropped into ice ether to produce a large amount of yellow precipitate. The precipitate was filtered by Buchner funnel, collected in a small beaker, dissolved in 5 mL of ethanol, and loaded into a dialysis bag with a molecular weight cutoff (MWCO) of 2000 Da. Ethanol was selected as the dialysis medium for dialysis. The dialysis solution was replaced every 2 hours. After 24 hours of dialysis, the substance in the dialysis bag was taken for vacuum rotary evaporation to remove the solvent, and vacuum drying was performed to obtain the final product mPEG-PLys (Cur).

[0103] The final product mPEG-PLys (Cur) has the structural formula:

[0104]

[0105] Among them, m=114, x=6, y=7.

[0106] The detection object mPEG-PLys(Cur) in the following examples is the final product mPEG-PLys(Cur) obtained in Example 1.

[0107] Example 2 Fourier transform infrared spectroscopy

[0108] Use Fourier transform infrared spectrometer to measure the infrared absorption spectrum of the sample and analyze it, and observe the relationship between the characteristic peaks of each sample. Accurately weigh 1.0 mg of curcumin Cur, mPEG-PLys, and mPEG-PLys (Cur), and take 150 mg of kBr. If it is crystalline, it needs to be ground. The mass ratio is (sample: KBr = 1:150). After sufficient grinding, pour it into the tableting mold and press it into tablets. The pressure is about 5 Pa and wait for 30 seconds. Then continue to pressurize until the pressure reaches about 8 Pa for 0.5-1 min. The tablets are transparent or translucent and put into the machine. Analyze the samples according to the relevant characteristic absorption peaks. The results are as follows Figure 1 shown.

[0109] The infrared absorption peaks of each sample were measured by Fourier transform infrared spectrometer. According to current research, the infrared characteristic absorption peaks of Cur are 3357cm -1 Stretching of -OH group on benzene ring, 1586cm -1 Stretching vibration of benzene ring, 1513cm -1 Vibration of CC and CO groups, 1282 cm -1 The aromatic stretching vibration of the CO group; the infrared characteristic absorption peaks of mPEG-PLys are 1750-1680cm -1 C=O carbonyl, 1680-1630cm -1 R-NH-R' tertiary amide, 1275-1020cm - 1 CO ether bond, 3500-3400cm -1 NH2, 3000-2850cm -1 CH. Comparing MCur with the above characteristic peaks, the sample was successfully synthesized.

[0110] Example 3 H NMR spectrum of nanomicelles

[0111] The nuclear magnetic resonance hydrogen spectrum of the sample was measured and analyzed using a nuclear magnetic resonance spectrometer to observe the number, position, and integral of the corresponding hydrogen to determine the successful synthesis of the sample. Accurately weigh 1.0 mg of mPEG-PLys (Cur), dissolve it in 1.0 mL of dmso-d6, measure it with a nuclear magnetic resonance spectrometer, and analyze it using Mestrenova. The results are as follows: Figure 2 shown.

[0112] In this experiment, nuclear magnetic resonance hydrogen spectrum (1H NMR) was used to characterize the structure of mPEG-PLys (Cur). The results of the nuclear magnetic spectrum are as follows: 1H NMR(DMSO-d6,400MHz,ppm): δ7.60(m,16H,ArCH=CH),7.53-7.09(m,48H,Ar),6.82(m,16H,COCH=CH),6.17(t,16H,COCH2CO),4.08(s,13H,CH),3.85(s,48H, CH3),3.51(m,420H,OCH2CH2O),3.24(s,3H,CH3),3.15(s,26H,CH2CH2NH),2. 93-2.90(m,32H,CH2),2.70-2.65(m,32H,COCH2CH2),1.95-1.05(m,78H,CH2).

[0113] The determination of hydrogen nuclear magnetic resonance spectrum proved the successful synthesis of mPEG-PLys(Cur), providing structurally correct and pure raw materials for subsequent experiments.

[0114] Example 4 Particle size of nanomicelles

[0115] The particle size of the sample was measured by Malvern particle size analyzer for analysis, and the size of the nanoparticles and the stability of the nanomicelles were observed. 2.0 mg of mPEG-PLys (Cur) were accurately weighed, ultrasonically dispersed in 1 mL of ultrapure water, and filtered with a 0.45 μm microporous water filter to remove large particles aggregated in the solution. In order to form a stable micellar solution, the sample was allowed to stand for 2 hours after preparation. Three parallel experiments (n=3) were set up and measured with a Malvern particle size analyzer, and water was selected as the dispersant.

[0116] The particle size and distribution of the sample in aqueous solution were measured using a Malvern particle size analyzer. Figure 3 As shown. The average particle size of MCur is 147.6nm (PDI = 0.111). Through the particle size measurement of nanomicelles, each sample showed a relatively uniform particle size distribution range, and the particle size of the micelles was less than 200nm, which met the particle size requirements of the drug delivery system for the passive targeting effect of nanoparticles.

[0117] Example 5 Zeta potential of nanomicelles

[0118] The sample's Zeta was measured using a Malvern particle size analyzer to analyze and observe what kind of charge the nanoparticles carry. 2.0 mg of mPEG-PLys (Cur) was accurately weighed, ultrasonically dispersed in 2 mL of 0.1 mmol / L KCl solution, and filtered with a 0.45 μm microporous water filter to remove large particles aggregated in the solution. In order to form a stable micellar solution, the sample was allowed to stand for 2 hours after preparation. Three parallel experiments (n=3) were set up and measured using a Malvern particle size analyzer, and water was selected as the dispersant.

[0119] The Zeta potential of each sample was measured by Malvern particle size analyzer. Figure 4 As shown in Figure 2, the nanomicelles are positively charged with an average potential of 20.5 mV. Because the surface of the Porphyromonas gingivalis membrane is negatively charged, the drug can better interact with the bacterial membrane electrostatically, leading to the leakage of proteins and other bacterial components, further enhancing the penetration ability of bacteria.

[0120] Example 6 Critical micelle concentration analysis (CMC) of nanomicelles

[0121] The concentration of the stimuli-responsive nanoparticles forming stable micelles in aqueous solution was analyzed by fluorescence spectrophotometer. 25.0 mg mPEG-PLys (Cur) was accurately weighed and placed in a 50 mL beaker, dissolved in ultrapure water, transferred to a 10 mL volumetric flask, fixed to volume with ultrapure water, and prepared into a 2500 μg / mL mother solution, which was then diluted to 100, 50, 25, 12.5, 10, 8, 5, 2.5, 1.25, 1, 0.8, and 0.5 μg / mL concentrations. Each group of samples was ultrasonically dispersed for 5 minutes to make them uniformly dispersed, and then filtered through a 0.45 μm water-based microporous filter to remove aggregated macromolecules. The entire preparation and treatment process required light protection. Measure the fluorescence intensity of each sample (fluorescence measurement conditions: excitation wavelength λex = 480nm, receiving range λem = 500-700nm, Ex and Em slit widths are both 5nm, sample cell thickness 1cm), and record the fluorescence absorbance value of the sample at 484nm. Draw a graph and calculate the critical micelle concentration of the sample. Figure 5 As shown, as an indicator of micelle stability, the critical micelle concentration (CMC) value was determined using a probe-free method because curcumin itself is fluorescent. The corresponding CMC was 13.86 ± 1.18 μg / mL. The low CMC value indicates that the nanomicelles have good stability, making them better for in vivo application.

[0122] Example 7 Ability of Nanomicelles to Generate Active Oxygen

[0123] The ability of stimulus-responsive nanoparticles to generate reactive oxygen species was analyzed using a multifunctional microplate reader. 2.0 mg of mPEG-PLys (Cur) was accurately weighed and placed in a small brown bottle. It was dissolved in 4 mL of ultrapure water to prepare a 0.5 mg / mL solution. The samples were grouped, including an ultrasonic group (MCur+H2O) and a non-ultrasonic group (MCur+H2O). Then 100 μL of DCFH-DA (100 μM) and 100 μL of each sample solution were added to a 96-well black board, respectively, with a total volume of 200 μL. Each group was set up as a parallel group (n=3). At the same time, a blank group (including an ultrasonic group and a non-ultrasonic group) was set up, that is, 100 μL of ultrapure water and 100 μL of DCFH-DA were mixed into a 96-well black board, and a parallel group (n=3) was set up. The excitation wavelength λex=485 nm, the receiving range λem=530 nm, and the ultrasound selection was 1 MHz, 50% duty cycle, 1 W / cm 2 ,5min, the results are as follows Figure 6 shown.

[0124] The ROS probe was used to measure the ability of the nanomicelles to produce reactive oxygen species under different conditions in the experimental group. Through data analysis, the ultrasound group (blank group was 1597, MCur+H2O was 1123) was significantly stronger than the non-ultrasound group (blank group was 287, MCur+H2O was 4506). At the same time, under the same conditions, the drug group had a stronger ability to produce ROS than the blank group. The results showed that the nanomicelles can have a good SDT effect.

[0125] Example 8 Nanomicelle Particle Size Stability

[0126] 10.0 mg of mPEG-PLys (Cur) was accurately weighed and dispersed in ultrapure water and buffer solution (acetic acid-sodium acetate solution containing 1 mM H2O2, pH = 5.0) respectively, with a final concentration of 500 μg / mL. The particle size changes of the micelles were then measured using a Malvern particle size analyzer at 0, 1, 2, 3, 4, 8, 12, 24, and 48 hours. The results are shown in Figure 2. Figure 7 shown.

[0127] Ultrapure water UPW and a slightly acidic aqueous solution containing H2O2 were selected as the release medium for in vitro particle size change experiments. UPW simulates the normal physiological environment, and the slightly acidic aqueous solution containing H2O2 simulates the environment inside bacteria. As shown in the figure, the particle size of MCur has certain changes in UPW and slightly acidic aqueous solutions containing H2O2. Among them, under the UPW condition, the change in MCur particle size is small within 48 hours, and the particle size is about 230nm at 48 hours. The reason is that the nanomicelles will condense over time. The particle size of MCur in the slightly acidic aqueous solution containing H2O2 changes more. As time goes by, the particle size of the nanocarrier changes from 165nm to about 490nm. The large change in the particle size of the nanocarrier over time is due to the degradation of MCur in a high concentration of H2O2 and a slightly acidic environment, which in turn affects the particle size.

[0128] Example 9 Ability of Nanomicelles to Treat Periodontitis in Vivo

[0129] Twenty rats were randomly divided into four groups, including a blank group, a positive control group, an mPEG-PLys (Cur) group, and an mPEG-PLys (Cur) ultrasound group. The blank group was healthy rats without any treatment, the positive control group was rats with periodontitis smeared with PBS solution, the mPEG-PLys (Cur) group was rats with periodontitis treated with medication, and the mPEG-PLys (Cur) ultrasound group was rats with periodontitis treated with medication and ultrasound). The rats with periodontitis were smeared with 100 μL of PBS solution and a treatment solution with a concentration of 200 μg / mL (mPEG-PLys (Cur), the solvent was PBS solution). After 5 minutes of medication, ultrasound was performed on the periodontitis lesions in the mPEG-PLys (Cur) ultrasound group. The above medication was given once every three days for five consecutive times. The rats were euthanized three days after the last medication, and the palatal and buccal periodontal tissues were collected for pathological sections to observe the effect of treating periodontitis. The ultrasound was selected at 1 MHz, 50% duty cycle, 1 W / cm 2 ,5min.

[0130] Pathological sections were used to observe the infiltration of immune cells, tissue disorder and edema in each group. The positive control group had the largest number of immune cell infiltrations accompanied by tissue disorder and edema, and the treatment group had a significant improvement compared with the positive control group. The results showed that the nanomicelles can have good periodontitis treatment capabilities.

[0131] Advantages of the present invention in the field of chemically modified curcumin:

[0132] The article Curcumin-loaded redox response of self-assembled micelles for enhanced antitumor and anti-inflammation efficacy reported that the loading capacity of curcumin by chemical modification was 7.62 and 8.21 wt%, respectively, while the loading capacity of curcumin in the present invention reached 16-20 wt%. The article A robust ROS generation nanoplatform combating periodontitis via sonodynamic / chemodynamic combination therapy reported that the drug in this study could generate 2.5×10 3 au, whereas in the present invention, the amount of active oxygen generated is 4.5×10 3 It can be seen that the present invention has certain advantages in application.

[0133] Although the embodiments of the present invention are disclosed for illustrative purposes, those skilled in the art will appreciate that various substitutions, changes and modifications are possible without departing from the spirit and scope of the present invention and the appended claims. Therefore, the scope of the present invention is not limited to the contents disclosed in the embodiments.

Claims

1. A polyethylene glycol-polylysine-curcumin polymicelle, characterized in that: Its structural formula is shown in formula (I): Here, m represents 114 to 227, x represents 5 to 10, and y represents 4 to 8.

2. The polyethylene glycol-polylysine-curcumin polymicelle according to claim 1, characterized in that: The average particle size of the polyethylene glycol-polylysine-curcumin polymicelles is 147.6 nm, and the average Zeta potential is 20.5 mV.

3. The method for preparing the polyethylene glycol-polylysine-curcumin polymicelles as claimed in claim 1 or 2, characterized in that: The following steps are involved: Acylation of 3,3'-thiodipropionic acid with oxalyl chloride to generate 3,3'-thiodipropionic acid chloride; Mixing the curcumin solution with pyridine used as an acid binding agent to obtain a curcumin mixed solution; The chlorinated 3,3'-thiodipropionic acid and curcumin mixed solution are stirred and mixed at a temperature below 0°C, reacted at room temperature for 3 to 5 hours, and purified to obtain a curcumin derivative containing a single sulfur bond; Deprotecting polylysine modified by N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide to obtain deprotected modified polylysine; The modified polylysine is subjected to a condensation reaction with N, N-diisopropylethylamine, and then mixed with a curcumin derivative containing a single sulfide bond activated by 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole carboxyl group, and stirred in the dark for 24 to 48 hours for an amidation reaction; the mixture is precipitated with ice ether, dialyzed and freeze-dried to obtain a polyethylene glycol-polylysine-curcumin polymer.

4. The preparation method according to claim 3, characterized in that: The step of reacting 3,3'-thiodipropionic acid with oxalyl chloride to generate chlorinated 3,3'-thiodipropionic acid is specifically as follows: Dissolve 3,3'-thiodipropionic acid in anhydrous tetrahydrofuran, add co-solvent N,N-dimethylformamide, slowly add oxalyl chloride under stirring below 0°C, and then stir at room temperature for 2-3h to obtain chlorinated 3,3'-thiodipropionic acid; Alternatively, the step of mixing the curcumin solution with pyridine used as an acid binding agent is specifically: Dissolve curcumin in anhydrous tetrahydrofuran, add pyridine and stir to obtain a curcumin mixed solution; Alternatively, the preparation steps of the curcumin derivative containing a single sulfide bond are specifically as follows: Under the condition of below 0°C, slowly drop 3,3'-thiodipropionic acid chloride into the curcumin mixed solution and stir, while protecting from light, transfer to room temperature and stir for 3-5 hours. After the reaction is completed, remove anhydrous tetrahydrofuran by rotary evaporation, dissolve with dichloromethane, extract and wash with hydrochloric acid, collect the organic phase and spin dry to obtain a curcumin derivative containing a single sulfur bond; The obtained curcumin derivative containing a single sulfide bond is dissolved in dichloromethane, and a mixed solution of dichloromethane and methanol is used as an eluent and a developing agent. The target product is confirmed by continuously spotting the plate until it is completely out of the column. The product is collected, spin-dried, and dried to obtain a purified curcumin derivative containing a single sulfide bond. Alternatively, the specific preparation steps of the N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide modified polylysine are: Methoxypolyethylene glycol amine and N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide are placed in a round-bottom flask, and N,N-dimethylformamide DMF is added to dissolve, and chloroform is used as a co-solvent to dissolve, and the mixture is vacuumed, protected by inert gas, and stirred at 40-50° C. to react; after 3 days, the reaction solution is treated by rotary evaporation under reduced pressure, and then dripped into ice ether drop by drop to precipitate a white flocculent precipitate, and the precipitate is filtered out with a Buchner funnel, and vacuum dried to obtain modified polylysine; The modified polylysine was dissolved in 0.5N sodium hydroxide aqueous solution and stirred at room temperature for 2 to 5 hours. After the reaction, the reaction solution was placed in a dialysis bag with a molecular weight cutoff (MWCO) of 1000Da for water dialysis. The ultrapure water was replaced every 2 hours. After 24 hours, the sample in the dialysis bag was taken out and placed in a freeze dryer for freeze drying to obtain the modified polylysine with deprotected groups.

5. The preparation method according to claim 4, characterized in that: The molar ratio of 3,3'-thiodipropionic acid to oxalyl chloride is 1:1.2; Alternatively, the molar ratio of curcumin to pyridine is 1:10; Alternatively, the molar ratio of the chlorinated 3,3'-thiodipropionic acid to curcumin is 1:1; Alternatively, when the dichloromethane and methanol mixture is used as the eluent, the volume ratio of dichloromethane:methanol is 400:3, and when the dichloromethane and methanol mixture is used as the developing solvent, the volume ratio of dichloromethane:methanol is 100:3; Alternatively, the molar ratio of the methoxypolyethylene glycol amine to N-[4-(2,5-dioxo-4-oxazolidinyl)butyl]-2,2,2-trifluoroacetamide is 1:15; Alternatively, the methoxypolyethylene glycol amine is mPEG4000-mPEG12000.

6. The preparation method according to claim 3, characterized in that: The method further comprises the step of preparing polyethylene glycol-polylysine-curcumin nano-micelles from polyethylene glycol-polylysine-curcumin polymers, specifically: The polyethylene glycol-polylysine-curcumin polymer is dissolved in N,N-dimethylformamide, and added into a dialysis bag with a molecular weight cutoff (MWCO) of 2000Da. Ultrapure water is selected as the medium, and the dialysis is performed in the dark for 24 hours. The ultrapure water is replaced every 2 hours for the first 12 hours, and every 6 hours for the next 12 hours. After 24 hours, the dialysis is stopped, the solution is centrifuged, the supernatant is filtered with a 0.45μm microporous water filter membrane, and the filtrate is placed in a freeze dryer for freeze drying, and the freeze-dried product is the polyethylene glycol-polylysine-curcumin nano-micelles.

7. The preparation method according to any one of claims 3 to 6, characterized in that: The specific steps of the polyethylene glycol-polylysine-curcumin polymer are: The purified curcumin derivative containing a single sulfide bond is dissolved in dichloromethane, and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole are added for activation, and the mixture is kept at room temperature in the dark for 3 to 4 hours to obtain the activated curcumin derivative containing a single sulfide bond; N, N-diisopropylethylamine was dropped into the modified polylysine with deprotected groups, and then dichloromethane was added to completely dissolve it for condensation reaction; The modified polylysine with the deprotected group after the condensation reaction is added to the activated curcumin derivative containing a single sulfide bond, and the reaction is carried out at 20-30°C in the dark for 24-48 hours. After the reaction is completed, the reaction solution is concentrated by vacuum rotary evaporation and dropped into ice ether to produce a yellow precipitate; the precipitate is filtered out by Buchner funnel, collected, dissolved in ethanol, and then placed in a dialysis bag with a molecular weight cutoff (MWCO) of 2000Da for dialysis, and ethanol is selected as the dialysis medium; the dialysis solution is replaced every 2 hours, and after dialysis in the dark for 24 hours, the substance in the dialysis bag is taken out for vacuum rotary evaporation to remove the solvent, and vacuum drying is performed to obtain a polyethylene glycol-polylysine-curcumin polymer.

8. The preparation method according to claim 7, characterized in that: The molar ratio of the purified curcumin derivative containing a monosulfide bond, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and 1-hydroxybenzotriazole is 1.5:1:1; Alternatively, the molar ratio of the deprotected modified polylysine and N,N-diisopropylethylamine is 1:5; Alternatively, the molar ratio of the purified curcumin derivative containing a monosulfide bond to the deprotected modified polylysine is 1:2.

5.

9. Use of the polyethylene glycol-polylysine-curcumin polymer as claimed in claim 1 or 2 in drug delivery.

10. Use of the polyethylene glycol-polylysine-curcumin polymer according to claim 1 or 2 in preparing a drug for treating periodontitis.

Citation Information

Patent Citations

  • Method for preparing curcumin micelle with high medicine loading

    CN102600063A

  • Curcumin prodrug micelle with oxidation and reduction sensitivity, micellar monomer and preparation method of micellar monomer

    CN103720675A

  • Curcumin-containing polymeric micelle drug delivery system and preparation method and application thereof

    CN105395481A

  • Polylysine nano prodrug micelle with charge turning and targeting functions and preparation and application thereof

    CN105561332A

  • Polyethylene glycol-chitosan-curcumin polymer, drug-loaded nano particles thereof and preparation method thereof

    CN109010846A

Cited By

  • CuTA-Poratepsilon-PL nano platform as well as preparation method and application thereof

    CN119732929A

  • Slow-release oral preparation based on ground lactose and preparation method thereof

    CN120346153A

  • Composite gel material for gum hemostasis and preparation method thereof

    CN121371267A

  • A composite gel material for gingival hemostasis and its preparation method

    CN121371267B